Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #783

    didn't check but could be an all time high % change over last year...

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #784

      asco abstracts are released at 23.00 tonight

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #785

        Thanks E L & Bulder

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #786

          good luck Helge, looking forward to the summaries tomorrow morning 😉

          1 Reply Last reply
          0
          • DarvinD Offline
            DarvinD Offline
            Darvin
            wrote on sidst redigeret af
            #787

            Rigth EL 17.10 65% increase compared to april 2020 and 46,5% increase compared to først 4 months 2020. Excellent

            1 Reply Last reply
            0
            • Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktørH Offline
              Helge_LarsenPI-redaktør
              wrote on sidst redigeret af
              #788

              E L I play football tonight with the young people in the club. Must therefore, as usual, go to bed early and get up late tomorrow. 😄

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #789

                a much better way to spend your time lol, enjoy!

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #790

                  Well, glofi har 3 pts ud af 52 med CRS grade 3. Epco har ingen over grade 2. Glofi: CRS was mostly(!) manageable.

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    peter12
                    wrote on sidst redigeret af
                    #791

                    Media release https://ir.genmab.com/news-releases/news-release-details/genmab-announces-abstracts-evaluating-products-pipeline

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #792

                      Responser synes jeg er svært at udlede, men epco nævner 55% CR og glofi nævner 57,1% CMR i dlbcl. Altså næsten det samme. Med alle forbehold.

                      1 Reply Last reply
                      0
                      • Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktørH Offline
                        Helge_LarsenPI-redaktør
                        wrote on sidst redigeret af
                        #793

                        Genmab vil præsentere data til kommende konferencer - GENT
                        https://www.proinvestor.com/investornyt/675234/genmab-vil-praesentere-data-til-kommende-konferencer-gent

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #794

                          God morgen. 🙂

                          1 Reply Last reply
                          0
                          • Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktørH Offline
                            Helge_LarsenPI-redaktør
                            wrote on sidst redigeret af
                            #795

                            Genmab Announces Abstracts Evaluating Products in Pipeline, Portfolio to be
                            Presented at American Society of Clinical Oncology : https://www.proinvestor.com/investornyt/675232/genmab-announces-abstracts-evaluating-products-in-pipeline-portfolio-to-be-presented-at-american-society-of-clinical-oncology

                            1 Reply Last reply
                            0
                            • Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktørH Offline
                              Helge_LarsenPI-redaktør
                              wrote on sidst redigeret af
                              #796

                              Torsdagens danske avisuddrag med Bitcoin, Salling Group og Rockwool: https://www.proinvestor.com/investornyt/675239/torsdagens-danske-avisuddrag-med-bitcoin-salling-group-og-rockwool

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #797

                                Er svagheden i biotekaktier forbigående?
                                Bryder Novo Nordisk ud af sit kursinterval? Er inflationsfaren reel – eller er det et buzzword? Samt verden ifølge elonmusk
                                & tsla. Lyt med i afsnit 66 af Investeringspodcasten med PerNordnet
                                ogHelgeLarsen. https://www.nordnet.dk/blog/afsnit-66-af-investeringspodcasten-om-biotekaktier-og-verden-ifoelge-elon-musk/
                                .

                                1 Reply Last reply
                                0
                                • SolsenS Offline
                                  SolsenS Offline
                                  Solsen
                                  wrote on sidst redigeret af
                                  #798

                                  Bemærkningen “mostly manageable” er da interessant, som også bulder fremhæver 23:35

                                  1 Reply Last reply
                                  0
                                  • JørgenVarnæsJ Offline
                                    JørgenVarnæsJ Offline
                                    JørgenVarnæs
                                    wrote on sidst redigeret af
                                    #799

                                    Bulder 13.56 tusind tak for info

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #800

                                      ASCO : Updated phase 1 results of teclistamab - https://meetinglibrary.asco.org/record/195433/abstract

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #801

                                        ASCO : Updated results of a phase 1, first-in-human study of talquetamab - https://meetinglibrary.asco.org/record/195432/abstract

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #802

                                          I didn't realise JNJ are also trying Amivantamab subcutaneous WITHOUT hyaluronidase , so just SC administration of a low concentration (50 mg/mL) formulation of amivantamab alone. Let's hope that works well enough. https://meetinglibrary.asco.org/record/201164/abstract

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger